UGT1A1
Showing 1 - 25 of >10,000
UGT1A1 Genotyping in Taiwanese Cancer Patients
Not yet recruiting
- The Influence of the UGT1A1 Genotype
- (no location specified)
Mar 20, 2023
Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))
Not yet recruiting
- Metastatic Pancreatic Cancer
- Low Dose OXIRI (LD-OXIRI)
-
Singapore, SingaporeNational Cancer Centre, Singapore
Jun 29, 2023
Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)
Completed
- Immune System Disorder (Healthy Volunteers)
- Belumosudil
- +3 more
-
Miami, FloridaInvestigational Site Number: 8400001
Apr 11, 2023
Metastatic Colorectal Cancer Trial in Kaohsiung (UGT1A1 genotyping (6,6), UGTIA1 genotyping (6,7), UGTIA1 genotyping (7,7))
Completed
- Metastatic Colorectal Cancer
- UGT1A1 genotyping (6,6)
- +7 more
-
Kaohsiung, TaiwanChung-Ho Memorial Hospital, Kaohsiung Medical University:
Nov 9, 2021
(CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of
Recruiting
- Colorectal Neoplasms
-
Maastricht, Limburg, NetherlandsMaastricht UMC+
Jan 10, 2023
Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)
Not yet recruiting
- Cancer
- DPYD or UGT1A1 variants
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Rectal Cancer Stage III Trial in Hangzhou (Neoadjuvant chemoradiotherapy based on irinotecan)
Recruiting
- Rectal Cancer Stage III
- Neoadjuvant chemoradiotherapy based on irinotecan
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Dec 7, 2021
Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics
Recruiting
- Gastrointestinal Cancer
- +4 more
- Availability of clinical decision support based on pharmacogenomic results.
-
Chicago, IllinoisUniversity of Chicago Medical Center
Oct 20, 2022
Solid Tumors, Hematological Malignancies Trial in Santa Monica, Whittier, Canton (Belinostat IV)
Completed
- Solid Tumors
- Hematological Malignancies
- Belinostat IV
-
Santa Monica, California
- +2 more
Sep 10, 2021
Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Adenocarcinoma Trial in Chicago (Oxaliplatin, Docetaxel,
Recruiting
- Pancreatic Adenocarcinoma
- +2 more
- Oxaliplatin
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jun 7, 2021
Crigler-Najjar Syndrome Trial in France, Italy, Netherlands (GNT0003)
Recruiting
- Crigler-Najjar Syndrome
- GNT0003
-
Clamart, France
- +3 more
Jun 1, 2021
Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)
Completed
- Diabetes Mellitus
- Sotagliflozin (SAR439954)
- Mefenamic acid
-
Gières, FranceInvestigational site 250001
Apr 21, 2022
Colorectal Cancer Trial in France (bevacizumab, fluorouracil, irinotecan HCl)
Completed
- Colorectal Cancer
- bevacizumab
- +3 more
-
Abbeville, France
- +31 more
Nov 5, 2020
Colorectal Cancer Trial (bevacizumab, filgrastim, fluorouracil)
Completed
- Colorectal Cancer
- bevacizumab
- +4 more
- (no location specified)
Mar 27, 2020
Pharmacogenomics Trial (Indapamide 1.5 MG SR)
Not yet recruiting
- Pharmacogenomics
- Indapamide 1.5 MG SR
- (no location specified)
Mar 15, 2022
Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)
Recruiting
- Esophageal Squamous Cell Carcinoma Abdominal Stage 0
- PD-1 Inhibitors
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 20, 2023
Healthy Participants Trial in Lenexa (BMS-986165, diflunisal)
Completed
- Healthy Participants
-
Lenexa, KansasPRA Health Sciences - Lenexa
Aug 3, 2020
CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic
Completed
- Metastatic Colorectal Cancer
- CPT-11 based regimens
-
Tokorozawa-shi, Saitama, JapanDepartment of Clinical Oncology, National Defense Medical Colleg
May 24, 2019
Metastatic Colorectal Cancer Trial in Kaohsiung (Regorafenib, UGT1A1 genotyping (TA6/TA6), UGT1A1 genotyping (TA6/TA7))
Unknown status
- Metastatic Colorectal Cancer
- Regorafenib
- +4 more
-
Kaohsiung, TaiwanChung-Ho Memorial Hospital, Kaohsiung Medical University:
Mar 19, 2019
CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in
Completed
- Small Cell Lung Cancer
- +4 more
- CPT-11
- Platinum analogues
-
Tokorozawa, JapanDepartment of Obstetrics and Gynecology, National Defense Medica
May 21, 2019
Myotonic Dystrophy 1 Trial (ARO-DM1 for Injection, Placebo)
Not yet recruiting
- Myotonic Dystrophy 1
- ARO-DM1 for Injection
- Placebo
- (no location specified)
Nov 14, 2023
Type 1 Diabetes, Type 1 Diabetes With Hypoglycemia, Type 1 Diabetes With Hyperglycemia Trial in Berne (Lab Demo 1.0)
Not yet recruiting
- Type 1 Diabetes Mellitus
- +2 more
- Lab Demo 1.0
-
Berne, SwitzerlandMarkus Laimer
Oct 23, 2023
ALDH1A1 Expression in Invasive Mammary Carcinoma
Enrolling by invitation
- Breast Cancer
-
Sohag, EgyptFaculty of Medicine
Nov 12, 2023
MicroRNA-1 and MicroRNA-133a Levels After Acute Exercise in
Recruiting
- To Determine the Levels of miRNA1 and miRNA133a Before and After Exercise
- miRNA levels analysis from saliva samples
-
Istanbul, TurkeyYeditepe University
Oct 11, 2023